Characterization of [I-125]-endothelin-1 and [I-125]-BQ3020 binding to rat cerebellar endothelin receptors

被引:7
作者
Widdowson, PS [1 ]
Kirk, CNP [1 ]
机构
[1] ICI PLC,CENT TOXICOL LAB,NEUROTOXICOL RES GRP,MACCLESFIELD SK10 4TJ,CHESHIRE,ENGLAND
关键词
endothelin receptor subtypes; I-125]-endothelin-1; I-125]-BQ3020; I-125]-PD151242; rat cerebellum;
D O I
10.1111/j.1476-5381.1996.tb15652.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We performed radioligand binding experiments on rat cerebellar homogenates using [I-125]-endothelin-1 ([I-125]-ET-1) and [I-125]-BQ3020 to examine the pharmacology of endothelin receptors in rat brain. Saturation experiments demonstrated a single population of binding sites with high affinity for both radioligands ([I-125]-ET-1, pK(d)=8.94+/-0.17; [I-125]-BQ3020, pK(d)=9.18+/-0.14 nM; mean+/-s.e.mean). However, [I-125]-BQ3020 only recognised approximately one third the number of endothelin receptors measured with [I-125]-ET-1. 2 Saturation binding experiments with [I-125]-PD151242 revealed high affinity binding to a single population of ET(A) receptors in the cerebellar homogenates (pK(d)=9.95+/-0.14; B-max=30+/-15 fmol mg(-1) protein). 3 Competition experiments were performed with ligands that are either non-selective or selective for endothelin receptor subtypes. The rat cerebellar endothelin receptor displayed a high affinity for endothelin-1 (ET-1), endothelin-3 (ET-3) and sarafotoxin-S6c (STX-6c) although the affinity for ET-3 was slightly higher than the affinity for ET-1 using both radioligands. The selective ET(A) antagonists, BQ123, EMS-182,874 and JKC-301 all displayed low affinities at the endothelin receptors. In contrast the selective ET(B) agonists, IRL1620 and [Ala(1,3,11,15])ET-1 and the selective ET(B) antagonist, BQ-788 had moderate affinities at the endothelin receptor, in the low nanomolar range. The ET(B) agonist, BQ3020, had approximately 10 fold higher affinity than IRL1620 and [Ala(1,3,11,15)]ET-1 at the rat cerebellar endothelin receptors. The non-selective antagonists, Re-46,2005, Re-47,0203 and PD-142,893 displayed moderate affinities at the cerebellar receptor. 4 Since [I-125]-BQ3020 recognises only a fraction of the [I-125]-ET-1 binding sites, the majority of the endothelin receptors in the cerebellum cannot be classed as ET(B). Although [I-125]-PD151242 was able to detect ET(A) receptors in the rat cerebellar homogenates, the small population of ET(A) receptors (2% of the total endothelin population as measured with [I-125]-ET-1) could not account for the non-ET(B) receptor population. We conclude that the rat brain cerebellar receptor has a profile similar to the ET(B1) receptor as it has a high affinity for ET-I, ET-3, STX-6c and was moderately sensitive to PD-142,893. However, as the ET(B) ligands BQ-788, IRL1620 and [Ala(1,3,11,15])ET-1 have only a moderate affinity for the rat cerebellar endothelin receptor and since ET-3 has a higher affinity as compared to ET-1, our findings suggest that the rat cerebellum contains predominately ET(c) receptors.
引用
收藏
页码:2126 / 2130
页数:5
相关论文
共 35 条
  • [1] CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR
    ARAI, H
    HORI, S
    ARAMORI, I
    OHKUBO, H
    NAKANISHI, S
    [J]. NATURE, 1990, 348 (6303) : 730 - 732
  • [2] THE CURRENT ENDOTHELIN RECEPTOR CLASSIFICATION - TIME FOR RECONSIDERATION
    BAX, WA
    SAXENA, PR
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (10) : 379 - 386
  • [3] ENDOTHELIN SARAFOTOXIN RECEPTOR HETEROGENEITY - EVIDENCE FOR DIFFERENT GLYCOSYLATION IN RECEPTORS FROM DIFFERENT TISSUES
    BOUSSOMITTLER, D
    GALRON, R
    SOKOLOVSKY, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (03) : 921 - 926
  • [4] IN-VITRO CHARACTERIZATION OF RO 46-2005, A NOVEL SYNTHETIC NONPEPTIDE ENDOTHELIN ANTAGONIST OF ET(A) AND ET(B) RECEPTORS
    BREU, V
    LOFFLER, BM
    CLOZEL, M
    [J]. FEBS LETTERS, 1993, 334 (02): : 210 - 214
  • [5] CHARACTERIZATION OF 3 NONPEPTIDE ENDOTHELIN RECEPTOR LIGANDS USING HUMAN CLONED ET(A)-RECEPTOR AND ET(B)-RECEPTOR
    BUCHAN, KW
    ALLDUS, C
    CHRISTODOULOU, C
    CLARK, KL
    DYKES, CW
    SUMNER, MJ
    WALLACE, DM
    WHITE, DG
    WATTS, IS
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) : 1251 - 1257
  • [6] CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228
  • [7] PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    BURRI, K
    CASSAL, JM
    FISCHLI, W
    GRAY, GA
    HIRTH, G
    LOFFLER, BM
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    [J]. NATURE, 1993, 365 (6448) : 759 - 761
  • [8] IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST SB-209670
    DOUGLAS, SA
    EDWARDS, RM
    ELLIOTT, JD
    OHLSTEIN, EH
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (02) : 405 - 413
  • [9] SPECIFIC RECEPTORS FOR ENDOTHELIN-3 IN CULTURED BOVINE ENDOTHELIAL-CELLS AND ITS CELLULAR MECHANISM OF ACTION
    EMORI, T
    HIRATA, Y
    MARUMO, F
    [J]. FEBS LETTERS, 1990, 263 (02) : 261 - 264
  • [10] CHARACTERISTICS OF ENDOTHELIN RECEPTORS IN THE CENTRAL-NERVOUS-SYSTEM OF SPONTANEOUSLY HYPERTENSIVE RATS
    GULATI, A
    REBELLO, S
    [J]. NEUROPHARMACOLOGY, 1992, 31 (03) : 243 - 250